Optiver Holding’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
JT
CAM
Optiver Holding's LGND Position: Q2 2026 in Review
Optiver Holding opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 74 shares worth $23.4K. The stake represents ﹤0.01% of the portfolio and ranks #1461 among its holdings. This is a return to the name: Optiver Holding previously reported a position in LGND as recently as Q3 2025.
Optiver Holding first reported a position in LGND in Q3 2025 and has held it in 2 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Optiver Holding held 74 shares of Ligand Pharmaceuticals worth $23.4K as of Q2 2026.
- Ligand Pharmaceuticals was a new Optiver Holding position in Q2 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1461 holding.
- Optiver Holding first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
- 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.